The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Abstract
BACKGROUND: Cardiac troponins I (cTnI) and T (cTnT) have received international endorsement as the standard biomarkers for detection of myocardial injury, for risk stratification in patients suspected of acute coronary syndrome, and for the diagnosis of myocardial infarction. An evidence-based clinical database is growing rapidly for high-sensitivity (hs) troponin assays. Thus, clarifications of the analytical principles for the immunoassays used in clinical practice are important. CONTENT: The purpose of this mini-review is (a) to provide a background for the biochemistry of cTnT and cTnI and (b) to address the following analytical questions for both hs cTnI and cTnT assays: (i) How does an assay become designated hs? (ii) How does one realistically define healthy (normal) reference populations for determining the 99th percentile? (iii) What is the usual biological variation of these analytes? (iv) What assay imprecision characteristics are acceptable? (v) Will standardization of cardiac troponin assays be attainable? SUMMARY: This review raises important points regarding cTnI and cTnT assays and their reference limits and specifically addresses hs assays used to measure low concentrations (nanograms per liter or picograms per milliliter). Recommendations are made to help clarify the nomenclature. The review also identifies further challenges for the evolving science of cardiac troponin measurement. It is hoped that with the introduction of these concepts, both laboratorians and clinicians can develop a more unified view of how these assays are used worldwide in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This specific peptide (HWQIAYNEHQWQ) not only exhibits an impressive binding affinity (Kd) of 270 pM comparable to that of antibodies37, but also targets the central portion of cTnI (amino acid residues 114–144) with less susceptibility to proteolysis and is postulated to be an optimal targeting epitope to detect all forms of cTnI present in blood circulation38–40.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [40]
Citations
Cites
Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422
Thygesen, K. A. (2007) · Circulation · Cited by 3,126
Task Force Members, Thygesen, K. A., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,536
Self-citationCardiac troponin I. A marker with high specificity for cardiac injury.
Adams, J. E., Bodor, G. S., Dávila‐Román, V. G., Delmez, J. A., Apple, F. S., Ladenson, J. H., & Jaffe, A. S. (1993) · Circulation · doi:10.1161/01.cir.88.1.101 · Cited by 1,149
Self-citationde Lemos, J. A., Drazner, M. H., Omland, T., Ayers, C. R., Khera, A., Rohatgi, A. K., Hashim, I. A., Berry, J. D., Das, S. R., Morrow, D. A., et al. (2010) · JAMA · doi:10.1001/jama.2010.1768 · Cited by 1,103
Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay
Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A. S., & Katus, H. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.132654 · Cited by 1,087
deFilippi, C. R., de Lemos, J. A., Christenson, R. H., Gottdiener, J. S., Kop, W. J., Zhan, M., & Seliger, S. L. (2010) · JAMA · doi:10.1001/jama.2010.1708 · Cited by 715
Katus, H. A., Remppis, A. B., Scheffold, T., Diederich, K. W., & Kübler, W. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90466-x · Cited by 557
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., Christenson, R. H., Christenson, R. H., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.084194 · Cited by 475
Self-citationReichlin, T., Irfan, A. B., Twerenbold, R., Reiter, M., Hochholzer, W., Burkhalter, H., Bassetti, S., Steuer, S., Winkler, K., Peter, F., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.023937 · Cited by 459
A New Season for Cardiac Troponin Assays: It’s Time to Keep a Scorecard
Apple, F. S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.128363 · Cited by 441
Self-citationCardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarction
CUMMINS, B., Auckland, M. L., & Cummins, P. L. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90645-4 · Cited by 429
Wu, A. H. B., Feng, Y., Moore, R., Apple, F. S., McPherson, P., Buechler, K. F., & Bodor, G. S. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1198 · Cited by 391
Self-citationPathobiology of Troponin Elevations
White, H. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.029 · Cited by 378
Multicenter analytical evaluation of a high-sensitivity troponin T assay
Saenger, A. K., Beyrau, R., Braun, S., Cooray, R., Dolci, A., Freidank, H., Giannitsis, E., Gustafson, S. A., Handy, B. C., Katus, H. A., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.034 · Cited by 377
NACB Writing Group Members, Apple, F. S., Jesse, R. L., Newby, L. K., Wu, A. H. B., & Christenson, R. H. (2007) · Circulation · doi:10.1161/circulationaha.107.182881 · Cited by 308
Self-citationJaffe, A. S., Vasile, V. C., Milone, M., Saenger, A. K., Olson, K. N., & Apple, F. S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.026 · Cited by 285
Self-citationWu, A. H. B., Lu, Q. A., Todd, J., Moecks, J., & Wians, F. H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.107391 · Cited by 267
Katrukha, A. G., Bereznikova, A. V., Esakova, T. V., Pettersson, K., Lövgren, T., Severina, M. E., Pulkki, K., Vuopio-Pulkki, L.-M., & Gusev, N. B. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1379 · Cited by 266
NACB WRITING GROUP MEMBERS, Apple, F. S., Jesse, R. L., Newby, L. K., Wu, A. H. B., Rh, C., Rh, C., Apple, F. S., Cannon, C. P., Francis, G. S., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.084715 · Cited by 257
Self-citationInfluence of Population Selection on the 99th Percentile Reference Value for Cardiac Troponin Assays
Collinson, P. O., Heung, Y. M., Gaze, D. C., Boa, F. G., Senior, R., Christenson, R. H., & Apple, F. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.171082 · Cited by 254
Self-citationDegradation of cardiac troponin I: implication for reliable immunodetection
Katrukha, A. G., Bereznikova, A. V., Filatov, V. L., Esakova, T. V., Kolosova, O. V., Pettersson, K., Lövgren, T., Bulargina, T. V., Trifonov, I. R., Gratsiansky, N. A., et al. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2433 · Cited by 232
Ricchiuti, V., Voss, E. M., Ney, A. L., Odland, M. D., Anderson, P. A. W., & Apple, F. S. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.9.1919 · Cited by 207
Self-citationVenge, P., Johnston, N., Lindahl, B., & James, S. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.051 · Cited by 162
Biological and Analytical Variability of a Novel High-Sensitivity Cardiac Troponin T Assay
Vasile, V. C., Saenger, A. K., Kroning, J. M., & Jaffe, A. S. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.140616 · Cited by 154
Apple, F. S., Parvin, C. A., Buechler, K. F., Christenson, R. H., Wu, A. H. B., & Jaffe, A. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052886 · Cited by 135
Self-citationFrankenstein, L., Wu, A. H. B., Hallermayer, K., Wians, F. H., Giannitsis, E., & Katus, H. A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.158964 · Cited by 128
Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies
Eriksson, S., Halenius, H., Pulkki, K. J., Hellman, J., & Pettersson, K. S. I. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.040063 · Cited by 125
Standardization of Cardiac Troponin I Assays: Round Robin of Ten Candidate Reference Materials
Christenson, R. H., Duh, S., Apple, F. S., Bodor, G. S., Bunk, D. M., Dalluge, J. J., Panteghini, M., Potter, J. D., Welch, M. J., Wu, A. H. B., et al. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.431 · Cited by 111
Self-citationde Lemos, J. A., McGuire, D. K., Khera, A., Das, S. R., Murphy, S. A., Omland, T., & Drazner, M. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.017 · Cited by 103
Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance
Gaze, D. C., & Collinson, P. O. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2007.007229 · Cited by 102
Self-citationVoss, E. M., Sharkey, S. W., Gernert, A. E., Murakami, M. M., Johnston, R. B., Hsieh, C. C., & Apple, F. S. (1995) · PubMed · Cited by 101
Self-citationHallermayer, K., Klenner, D., & Vogel, R. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519909168336 · Cited by 100
Standardisation of cardiac troponin I measurement: past and present
Tate, J. R., Bunk, D. M., Christenson, R. H., Katrukha, A., Noble, J. E., Porter, R., Schimmel, H. G., Wang, L., & Panteghini, M. (2010) · Pathology · doi:10.3109/00313025.2010.495246 · Cited by 77
Apple, F. S., Simpson, P. A., & Murakami, M. M. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.05.014 · Cited by 75
Self-citationBiochemical Factors Influencing Measurement of Cardiac Troponin I in Serum
Katrukha, A., Bereznikova, A. V., Filatov, V. V., & Esakova, T. V. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.159 · Cited by 73
Serum and Plasma Cardiac Troponin I 99th Percentile Reference Values for 3 2nd-Generation Assays
Apple, F. S., & Murakami, M. M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.087718 · Cited by 44
Self-citationHigh-Sensitivity Cardiac Troponin: Hype, Help, and Reality
Jaffe, A. S., & Apple, F. S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.136218 · Cited by 39
Self-citationAssay Imprecision and 99th-Percentile Reference Value of a High-Sensitivity Cardiac Troponin I Assay
Collinson, P. O., Clifford-Mobley, O., Gaze, D. C., Boa, F. G., & Senior, R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.124925 · Cited by 37
Self-citationInfluence of Imprecision on ROC Curve Analysis for Cardiac Markers
Kupchak, P., Wu, A. H. B., Ghani, F., Newby, L. K., Ohman, E. M., & Christenson, R. H. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.064477 · Cited by 29
Size-Exclusion Chromatography of Circulating Cardiac Troponin T
Michielsen, E. C. H. J., Diris, J. H. C., Wodzig, W. K. W. H., & van Dieijen‐Visser, M. P. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.073858 · Cited by 9
Flagged first, then by citations
Research works printed but not linked: 1
- Apple, 2011, Short-term biological variation of cardiac troponin I measured with three high-sensitivity assays [Abstract], Clin Chem, 57, C05
Cited by
Sorted by citations
Third universal definition of myocardial infarction
the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., CHAITMAN, B. R., & White, H. D. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.122 · Cited by 6,585
Third universal definition of myocardial infarction
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Thygesen, K., Alpert, J. S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs184 · Cited by 3,095
Self-citationThird Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012) · Circulation · doi:10.1161/cir.0b013e31826e1058 · Cited by 2,985
Third Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., Simoons, M. L., CHAITMAN, B. R., White, H. D., Thygesen, K. A., Alpert, J. S., White, H. D., Jaffe, A. S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.001 · Cited by 2,619
Self-citationBraunwald, E. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 862
Metadata
- Authors
- Apple, F. S., Collinson, P. O., & for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers
- Affiliations
- University of Minnesota (US)
- St George's Hospital (GB)
- Corresponding author
- Apple, Fred S
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 58
- Issue
- 1
- Pages
- 54-61
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2151231511
- Cited by
- 861
- References
- 41
- Citations by year
- 2026: 26 · 2025: 39 · 2024: 33 · 2023: 42 · 2022: 44 · 2021: 51 · 2020: 53 · 2019: 58 · 2018: 63 · 2017: 87 · 2016: 88 · 2015: 69 · 2014: 75 · 2013: 81 · 2012: 46
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Siemens
- Abbott
- Radiometer
- B.R.A.H.M.S.
- Roche
- Alere
- Instrumentation Laboratories
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- high-sensitivity troponin I, high-sensitivity troponin T, cardiac troponin assays, assay standardization, reference limits, biological variation, assay imprecision, myocardial injury biomarkers, acute coronary syndrome, myocardial infarction diagnosis
- MeSH terms
- Humans, Immunoassay, Myocardial Infarction, Myocardium, Reference Values, Sensitivity and Specificity, Biomarkers, Troponin I, Troponin T, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review